Annexin Pharmaceuticals AB (publ) (STO: ANNX)
0.530
-0.024 (-4.33%)
Sep 2, 2024, 11:26 AM CET
ANNX Revenue
Annexin Pharmaceuticals AB had revenue of 16.16M SEK in the quarter ending June 30, 2024, with 20.43% growth. This brings the company's revenue in the last twelve months to 62.59M, up 26.77% year-over-year. In the year 2023, Annexin Pharmaceuticals AB had annual revenue of 56.35M with 26.38% growth.
Revenue (ttm)
62.59M
Revenue Growth
+26.77%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
4
Market Cap
295.27M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 56.35M | 11.76M | 26.38% |
Dec 31, 2022 | 44.59M | 10.99M | 32.69% |
Dec 31, 2021 | 33.60M | 7.30M | 27.73% |
Dec 31, 2020 | 26.31M | 437.00K | 1.69% |
Dec 31, 2019 | 25.87M | 3.72M | 16.81% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca PLC | 520.76B |
ABB Ltd | 342.58B |
Investor AB (publ) | 240.73B |
Investor AB (publ) | 240.73B |
Atlas Copco AB | 177.12B |
Atlas Copco AB | 177.12B |
AB Volvo (publ) | 552.20B |
AB Volvo (publ) | 552.20B |